Business Context and Reporting Period
This Form 6-K filing by Deutsche Bank Aktiengesellschaft, dated October 27, 2014, covers the month of October 2014. The report incorporates two press releases issued on October 24 and October 26, 2014, regarding litigation costs for the third quarter of 2014 and the results of the European Central Bank (ECB) Comprehensive Assessment.
Key Financial Metrics
- Litigation Costs: EUR 894 million expected for the third quarter of 2014. These costs are largely not tax-deductible.
- Cumulative Litigation Costs: EUR 1.36 billion for the first nine months of 2014.
- Capital Raising: EUR 8.5 billion of common equity raised in the second quarter of 2014.
- Regulatory Capital Ratios (Pro-forma as of Jan 1, 2014):
- AQR-adjusted CRD4 CET1 Ratio: 13.33% (Threshold: 8.00%).
- Stress Test "Baseline" Scenario CET1 Ratio: 12.55% (Threshold: 8.00%).
- Stress Test "Adverse" Scenario CET1 Ratio: 8.78% (Threshold: 5.50%).
Note: The filing does not provide specific values for total revenue, net profit, operating cash flow, or total debt for the period.
Material Changes and Assessment Results
Deutsche Bank confirmed it successfully met all requirements of the ECB Comprehensive Assessment, which included an Asset Quality Review (AQR) and a Stress Test.
- Asset Quality Review: No significant adjustments were required to the Bank's values or ratios. The pro-forma CRD4 CET1 ratio remained almost unchanged at 13.33% after AQR adjustments.
- Stress Test Performance: The Bank exceeded minimum threshold levels in both baseline and adverse scenarios. The adverse scenario ratio of 8.78% exceeded the 5.50% threshold by 328 basis points.
- Impact of Capital Raise: The EUR 8.5 billion equity raise in Q2 2014 was not factored into the Comprehensive Assessment but is noted to have further strengthened the Bank's capital position post-assessment.
Outlook, Risks, and Management Commentary
Co-CEOs Jürgen Fitschen and Anshu Jain stated that the assessment reaffirms the Bank's capital base substantially exceeds regulatory requirements even under severe market stress. They emphasized that the rigorous assessment process strengthens confidence in the European banking system.
Risks and Contingencies:
- Litigation: Significant costs are expected, with EUR 894 million booked in Q3 2014. Potential litigation costs were explicitly excluded from the ECB Stress Test.
- Forward-Looking Risks: Results may differ due to financial market conditions in Germany, Europe, and the US; potential borrower or counterparty defaults; and the reliability of risk management policies.
- Unusual Items: The litigation costs are largely non-tax-deductible.
Investor Verification Checklist
- Verify the final unaudited third-quarter 2014 financial results scheduled for release on October 29, 2014, to confirm the exact impact of the EUR 894 million litigation charge on net income.
- Review the full 2013 Annual Report on Form 20-F (pages 11-25) for a detailed breakdown of risk factors referenced in this filing.
- Monitor future disclosures regarding the tax deductibility status of the litigation costs and any additional legal contingencies.
- Confirm the integration of the Q2 2014 capital raise into the Bank's ongoing regulatory capital reporting.